Assessment Tool: Uterine Fibroid Symptom and QOL symptom severity score
Need for further interventions
64 women had laparoscopic myomectomy | 68 women had MRgFUS
Median max fibroid diameter was 70 mm for both groups
Multiple fibroids more common in laparoscopic group
45.3% of laparoscopic group had with robotically assisted laparoscopic operation
Tended to be younger (38 years), with lower gravidity
There was no difference in the Uterine Fibroid Symptom and QOL symptom severity score questionnaire score (P=.439)
Analysis of each of the symptoms separately and multivariate analysis did not alter results
The rate of additional interventions was not significantly different (P=0.312)
Laparoscopic myomectomy: 5 (7.8%)
MRgFUS: 9 (13.2%)
Long-term outcome and rate of reinterventions were comparable after magnetic resonance–guided focused ultrasound treatment or laparoscopic myomectomy for uterine fibroid tumor
The authors state
…both treatments should be presented as possibilities to the appropriate patient, based on the similarity of the good clinical long-term results presented in this study. Further randomized prospective trials with 2 comparable populations are needed to strengthen these findings.
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan